Publications

Publications by Sigrid S. Skånland

28 publications found

Publications 2021

  1. Jiang X, Bergquist A, Löscher BS, Venkatesh G, Mold JE, Holm K, Laerdahl JK, Skånland SS, Maleki KT, Cornillet M, Taskén K, Franke A, Karlsen TH, Björkström NK, Melum E (2021)
    A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
    Sci Transl Med, 13 (582)
    DOI 10.1126/scitranslmed.abb0036, PubMed 33627483
  2. Skånland SS, Mato AR (2021)
    Overcoming resistance to targeted therapies in chronic lymphocytic leukemia
    Blood Adv, 5 (1), 334-343
    DOI 10.1182/bloodadvances.2020003423, PubMed 33570649

Publications 2020

  1. Mato AR, Roeker LE, Lamanna N, Allan JN, Leslie L, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, Huntington SF, Davids MS, Brown JR, Antic D, Jacobs R, Ahn IE, Pu J, Isaac KM, Barr PM, Ujjani CS, Geyer MB, Berman E, Zelenetz AD, Malakhov N, Furman RR et al. (2020)
    Outcomes of COVID-19 in patients with CLL: a multicenter international experience
    Blood, 136 (10), 1134-1143
    DOI 10.1182/blood.2020006965, PubMed 32688395
  2. Skånland SS, Karlsen L, Taskén K (2020)
    B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia
    Scand J Immunol, 92 (5), e12931
    DOI 10.1111/sji.12931, PubMed 32640099

Publications 2019

  1. Skånland SS, Cieślar-Pobuda A (2019)
    Off-label uses of drugs for depression
    Eur J Pharmacol, 865, 172732
    DOI 10.1016/j.ejphar.2019.172732, PubMed 31622593
  2. Skånland SS, Cremaschi A, Bendiksen H, Hermansen JU, Thimiri Govinda Raj DB, Munthe LA, Tjønnfjord GE, Taskén K (2019)
    An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL
    Leukemia, 34 (2), 478-487
    DOI 10.1038/s41375-019-0569-7, PubMed 31471562
  3. Skånland SS, Taskén K (2019)
    Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling
    J Immunol, 203 (4), 1055-1063
    DOI 10.4049/jimmunol.1801660, PubMed 31292214

Publications 2018

  1. Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Cryopreservation of primary B cells minimally influences their signaling responses
    Sci Rep, 8 (1), 17651
    DOI 10.1038/s41598-018-36121-9, PubMed 30518828
  2. Myhrvold IK, Cremaschi A, Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
    Oncotarget, 9 (10), 9273-9284
    DOI 10.18632/oncotarget.23949, PubMed 29507689
  3. Skånland SS (2018)
    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
    J Vis Exp (140)
    DOI 10.3791/58386, PubMed 30346411
  4. Thimiri Govinda Raj DB, Cremaschi A, Skånland SS, Gade A, Schjesvold FH, Tjønnfjord GE, Munthe LA, Tasken K (2018)
    In-Vitro Drug Sensitivity Screening in Chronic Lymphocytic Leukemia (CLL) Primary Patient Samples Identifies Drug Candidates for Precision Cancer Therapy
    Blood, 132, 4676
    DOI 10.1182/blood-2018-99-110357, PublikaID 304
  5. Thimiri Govinda Raj DB, Giliberto M, Cremaschi A, Skånland SS, Gade A, Tjønnfjord GE, Schjesvold FH, Munthe LA, Tasken K (2018)
    Drug Sensitivity Screening on Multiple Myeloma for Precision Cancer Therapy
    Blood, 132, 4677
    DOI 10.1182/blood-2018-99-110669, PublikaID 303

Publications 2015

  1. Parente-Ribes A, Skånland SS, Bürgler S, Os A, Wang D, Bogen B, Tjønnfjord GE, Taskén K, Munthe LA (2015)
    Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells
    Haematologica, 101 (2), e59-62
    DOI 10.3324/haematol.2015.135590, PubMed 26589914

Publications 2014

  1. Skånland SS, Moltu K, Berge T, Aandahl EM, Taskén K (2014)
    T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses
    Biochem J, 460 (3), 399-410
    DOI 10.1042/BJ20140040, PubMed 24665965

Publications 2013

  1. Gregers TF, Skånland SS, Wälchli S, Bakke O, Sandvig K (2013)
    BiP negatively affects ricin transport
    Toxins (Basel), 5 (5), 969-82
    DOI 10.3390/toxins5050969, PubMed 23666197

Publications 2012

  1. Kalland ME, Solheim SA, Skånland SS, Taskén K, Berge T (2012)
    Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
    Exp Cell Res, 318 (14), 1611-9
    DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621
  2. Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
    Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
    Arterioscler Thromb Vasc Biol, 33 (2), e47-55
    DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
  3. Tcatchoff L, Andersson S, Utskarpen A, Klokk TI, Skånland SS, Pust S, Gerke V, Sandvig K (2012)
    Annexin A1 and A2: roles in retrograde trafficking of Shiga toxin
    PLoS One, 7 (7), e40429
    DOI 10.1371/journal.pone.0040429, PubMed 22792315

Publications 2011

  1. Ikeda F, Deribe YL, Skånland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V, Terzic J, Tokunaga F, Androulidaki A, Nakagawa T, Pasparakis M, Iwai K, Sundberg JP, Schaefer L, Rittinger K, Macek B, Dikic I (2011)
    SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis
    Nature, 471 (7340), 637-41
    DOI 10.1038/nature09814, PubMed 21455181

Publications 2010

  1. Bethani I, Skånland SS, Dikic I, Acker-Palmer A (2010)
    Spatial organization of transmembrane receptor signalling
    EMBO J, 29 (16), 2677-88
    DOI 10.1038/emboj.2010.175, PubMed 20717138

Publications 2009

  1. Skånland SS, Wälchli S, Brech A, Sandvig K (2009)
    SNX4 in complex with clathrin and dynein: implications for endosome movement
    PLoS One, 4 (6), e5935
    DOI 10.1371/journal.pone.0005935, PubMed 19529763
  2. Skånland SS, Wälchli S, Sandvig K (2009)
    β-arrestins attenuate p38-mediated endosome to Golgi transport
    Cell Microbiol, 11 (5), 796-807
    DOI 10.1111/j.1462-5822.2009.01292.x, PubMed 19159388
  3. Wälchli S, Aasheim HC, Skånland SS, Spilsberg B, Torgersen ML, Rosendal KR, Sandvig K (2009)
    Characterization of clathrin and Syk interaction upon Shiga toxin binding
    Cell Signal, 21 (7), 1161-8
    DOI 10.1016/j.cellsig.2009.03.005, PubMed 19289168

Publications 2007

  1. Ménétret JF, Schaletzky J, Clemons WM, Osborne AR, Skånland SS, Denison C, Gygi SP, Kirkpatrick DS, Park E, Ludtke SJ, Rapoport TA, Akey CW (2007)
    Ribosome binding of a single copy of the SecY complex: implications for protein translocation
    Mol Cell, 28 (6), 1083-92
    DOI 10.1016/j.molcel.2007.10.034, PubMed 18158904
  2. Skånland SS, Wälchli S, Utskarpen A, Wandinger-Ness A, Sandvig K (2007)
    Phosphoinositide-regulated retrograde transport of ricin: crosstalk between hVps34 and sorting nexins
    Traffic, 8 (3), 297-309
    DOI 10.1111/j.1600-0854.2006.00527.x, PubMed 17319803
  3. Torgersen ML, Wälchli S, Grimmer S, Skånland SS, Sandvig K (2007)
    Protein kinase Cdelta is activated by Shiga toxin and regulates its transport
    J Biol Chem, 282 (22), 16317-28
    DOI 10.1074/jbc.M610886200, PubMed 17403690
  4. Utskarpen A, Slagsvold HH, Dyve AB, Skånland SS, Sandvig K (2007)
    SNX1 and SNX2 mediate retrograde transport of Shiga toxin
    Biochem Biophys Res Commun, 358 (2), 566-70
    DOI 10.1016/j.bbrc.2007.04.159, PubMed 17498660
  5. Wälchli S, Skånland SS, Gregers TF, Lauvrak SU, Torgersen ML, Ying M, Kuroda S, Maturana A, Sandvig K (2007)
    The Mitogen-activated protein kinase p38 links Shiga Toxin-dependent signaling and trafficking
    Mol Biol Cell, 19 (1), 95-104
    DOI 10.1091/mbc.e07-06-0565, PubMed 17959827

 
Page visits: 244